Tinea versicolor

	WikiDoc Resources for Tinea versicolor
Articles
Most recent articles on Tinea versicolor Most cited articles on Tinea versicolor Review articles on Tinea versicolor Articles on Tinea versicolor in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tinea versicolor Images of Tinea versicolor Photos of Tinea versicolor Podcasts & MP3s on Tinea versicolor Videos on Tinea versicolor
Evidence Based Medicine
Cochrane Collaboration on Tinea versicolor Bandolier on Tinea versicolor TRIP on Tinea versicolor
Clinical Trials
Ongoing Trials on Tinea versicolor at Clinical Trials.gov Trial results on Tinea versicolor Clinical Trials on Tinea versicolor at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tinea versicolor NICE Guidance on Tinea versicolor NHS PRODIGY Guidance FDA on Tinea versicolor CDC on Tinea versicolor
Books
Books on Tinea versicolor
News
Tinea versicolor in the news Be alerted to news on Tinea versicolor News trends on Tinea versicolor
Commentary
Blogs on Tinea versicolor
Definitions
Definitions of Tinea versicolor
Patient Resources / Community
Patient resources on Tinea versicolor Discussion groups on Tinea versicolor Patient Handouts on Tinea versicolor Directions to Hospitals Treating Tinea versicolor Risk calculators and risk factors for Tinea versicolor
Healthcare Provider Resources
Symptoms of Tinea versicolor Causes & Risk Factors for Tinea versicolor Diagnostic studies for Tinea versicolor Treatment of Tinea versicolor
Continuing Medical Education (CME)
CME Programs on Tinea versicolor
International
Tinea versicolor en Espanol Tinea versicolor en Francais
Business
Tinea versicolor in the Marketplace Patents on Tinea versicolor
Experimental / Informatics
List of terms related to Tinea versicolor

	Tinea versicolor;
ICD-10	B36.0
ICD-9	111.0
DiseasesDB	10071
MedlinePlus	001465
eMedicine	derm/423

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

Tinea versicolor or pityriasis versicolor is a common skin infection caused by the yeast Malassezia furfur (formerly termed Pityrosporum ovale). This yeast is normally found on the human skin and only becomes troublesome under certain circumstances, such as a warm and humid environment.

Symptoms

The symptoms of this condition include:

Generally oval or irregularly-shaped spots of 1/4 to 1 inch in diameter, often merging together to form a larger patch
Occasional fine scaling of the skin producing a very superficial ash-like scale
Pale, dark tan, or pink in color, with a reddish undertone that can darken when the patient is overheated, such as in a hot shower or during/after exercise
Sharp border

These spots commonly affect the back, underarm, upper arm, chest, lower legs, and neck. Occasionally it can also be present on the face. The yeasts can often be seen under the microscope within the lesions and typically have a so called "spaghetti and meat ball appearance" as the round yeasts produce filaments.

In people with dark skin tones, pigmentary changes such as hypopigmentation (loss of color) are common, while in those with lighter skin color, hyperpigmentation (increase in skin color) are more common. These discolorations have led to the term "sun fungus".

Diagnosis

Physical Examination

Skin

Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.[1]

Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]
Pityriasis versicolor. Adapted from Dermatology Atlas.^[1]

Prevalence

Tinea versicolor is a common condition. It is estimated that 2 to 8% of the population of the United States has it. This skin disease commonly affects adolescents and young adults, especially in warm and humid climates. It is thought that the yeast feeds on skin oils (lipids) as well as dead skin cells.

Treatment

Treatments for tinea versicolor include:

Topical antifungal medications - containing either 2.5% selenium sulfide (Selsun® shampoo in UK, but not Selsun Blue which contains only 1%) or 2% ketoconazole (Nizoral® ointment and shampoo) applied to dry skin and washed off after 10 minutes, repeated daily for 2 weeks. Other topical antifungal agents such as clotrimazole, miconazole or terbinafine are less widely recommended. Additionally, hydrogen peroxide has been known to lessen symptoms, and on certain occasions, remove the problem.
Oral antifungal prescription only medications include 400 mg of ketoconazole or fluconazole in a single dose, or ketoconazole 200 mg daily for 7 days, or itraconazole 400 mg daily for 3-7 days. The single-dose regimens can be made more effective by having the patient exercise 1-2 hours after the dose, to induce sweating. The sweat is allowed to evaporate, and showering is delayed for a day, leaving a film of the medication on the skin.
Recurrence is common and may be reduced by intermittent application of topical agents (such as tea tree oil) or adding a small amount of anti-dandruff shampoo to water used for bathing.

External links

Template:Mycoses

de:Pityriasis versicolor nl:Pityriasis versicolor sv:Pityriasis versicolor sr:Tinea_versicolor

Template:WH Template:WikiDoc Sources

↑ ^1.00 ^1.01 ^1.02 ^1.03 ^1.04 ^1.05 ^1.06 ^1.07 ^1.08 ^1.09 ^1.10 ^1.11 ^1.12 ^1.13 ^1.14 ^1.15 ^1.16 ^1.17 ^1.18 ^1.19 ^1.20 ^1.21 ^1.22 ^1.23 ^1.24 ^1.25 ^1.26 ^1.27 ^1.28 ^1.29 ^1.30 ^1.31 ^1.32 ^1.33 ^1.34 ^1.35 ^1.36 ^1.37 ^1.38 ^1.39 ^1.40 ^1.41 ^1.42 ^1.43 ^1.44 ^1.45 ^1.46 ^1.47 ^1.48 ^1.49 ^1.50 ^1.51 ^1.52 ^1.53 ^1.54 ^1.55 ^1.56 ^1.57 ^1.58 ^1.59 ^1.60 ^1.61 ^1.62 ^1.63 "Dermatology Atlas".

[Dermatology_Atlas-1] 1.00 ^1.01 ^1.02 ^1.03 ^1.04 ^1.05 ^1.06 ^1.07 ^1.08 ^1.09 ^1.10 ^1.11 ^1.12 ^1.13 ^1.14 ^1.15 ^1.16 ^1.17 ^1.18 ^1.19 ^1.20 ^1.21 ^1.22 ^1.23 ^1.24 ^1.25 ^1.26 ^1.27 ^1.28 ^1.29 ^1.30 ^1.31 ^1.32 ^1.33 ^1.34 ^1.35 ^1.36 ^1.37 ^1.38 ^1.39 ^1.40 ^1.41 ^1.42 ^1.43 ^1.44 ^1.45 ^1.46 ^1.47 ^1.48 ^1.49 ^1.50 ^1.51 ^1.52 ^1.53 ^1.54 ^1.55 ^1.56 ^1.57 ^1.58 ^1.59 ^1.60 ^1.61 ^1.62 ^1.63 "Dermatology Atlas".

[1]


Tinea versicolor
ICD-10	B36.0
ICD-9	111.0
DiseasesDB	10071
MedlinePlus	001465
eMedicine	derm/423